Recurrent malignant ascites is a common management problem in oncology and palliative care.
Discussion:
Here, we describe a case of malignant ascites managed by insertion of a Tenckhoff Catheter (TC), which resulted in successful symptomatic control and improvement in quality of life.
Get full access to this article
View all access options for this article.
References
1.
KeenA, FitzgeraldD, BryantA, DickinsonHO. Management of drainage for malignant ascites in gynaecological cancer. Cochrane Database Syst Rev, 2010; Jan20,1:CD007794.
2.
EassonA, BezjakA, RossAet al. Changes in symptoms after paracentesis for symptomatic malignant ascites. J Clin Oncol, 2005; 16,suppl:6071.
3.
SmithEM, JaysonGC. The current and future management of malignant ascites. Clin Oncol (R Coll Radiol), 2003; 15:59–72.
4.
RossGJ, KesslerHB, ClairMR, GatenbyRA, HartzWH, RossLV. Sonographically guided paracentesis for palliation of symptomatic ascites. AJR Am J Roentgenol, 1989; 153:1309–1311.
5.
MackeyJR, VennerPM. Malignant ascites: Demographics, therapeutic efficacy and predictors of survival. Can J Oncol, 1996; 6:474–480.
6.
PockrosPJ, EsrasonKT, NguyenC, DuqueJ, WoodS. Mobilisation of malignant ascites with diuretics is dependent on ascitic fluid characteristics Gastroenterology. 1992; 103:1302–1306.
7.
LorentzenT, SengelovL, NolsoeCP, KhattarSC, KarstrupS, Von Der Maase. Ultrasonographically guided insertion of a peritoneo-gastric shunt in patients' with malignant ascites. Acta Radiol, 1995; 36:481–484.
8.
RozenblitGN, Del GuercioLRM, RundbackJH, PoplauskyMR, LebovicsE. Peritoneal-urinary drainage for treatment of refractory ascites: A pilot study. J Vasc Interv Radiol, 1998; 9:998–1005.
9.
MamadaY, YoshidaH, TaniaiN, BandouK, ShimizuT, KakinumaD, MizuguchiY, IshikawaY, AkimaruK, TajiriT. Peritoneovenous shunts for palliation of malignant ascites. J Nippon Med Sch, 2007; 74:355–358.
10.
ZanonC, GrossoM, ApraF, ClaraR, BortoliniM, QuaglinoF, CornagliaS, SimoneP. Palliative treatment of malignant refractory ascites by positioning of Denver perioneovenous shunt. Tumori, 2002; 88:123–127.
11.
WickremesekeraSK, StubbsRS. Peritoneovenous shunting for malignant ascites. N Z Med J, 1997; 110:33–35.
12.
FaughtW, KirkpatrickJR, KrepartGV, HeywoodMS, LotockRJ. Peritoneovenous shunt for palliation of gynaecologic malignant ascites. J Am Coll Surg, 1995; 180:472–474.
13.
SchumacherDL, SaclaridesTJ, StarenED. Perioneovenous shunts for palliation of the patient with malignant ascites. Ann Surg Oncol, 1994; 1:378–381.
14.
GoughIR, BaldersonGA. Malignant ascites. A comparison of peritoneovenous shunting and non-operative management. Cancer, 1993; 71:2377–2382.
15.
RosenbergS, CourtneyA, NemcekAAJr, OmaryRA. Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Interv Radiol, 2004; 15:1129–1131.
16.
RichardHM3rd, ColdwellDM, Boyd-KranisRL, MurthyR, Van ExhoDA. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol, 2001; 12:373–375.
17.
OzkanO, AkinciD, GocmenR, CilB, OzmenM, AkhanO. Percuatneous placement of peritoneal port-catheter in patients with malignant ascites. Cardiovasc Intervent Radiol, 2007; 30:232–236.
18.
MercadanteS, IntravaiaG, FerreraP, VillariP, FabrizioDF. Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer, 2008; 16:975–978.
19.
O'NeillMJ, WeisslederR, GervaisDA, HahnPF, MuellerPR. Tunneled Peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol, 2001; 177:615–618.
20.
LomasDA, WallisPJW, StockleyRA. Palliation of malignant acites with a Tenckhoff catheter. Thorax, 1989; 44:828
21.
BuiCD, MartinCJ, CurrowDC. Case report: Effective community palliation of intractable malignant ascites with a permanently implanted abdominal drain. J Palliat Med, 1999; 2:319–321
22.
BarnettTD, RubinsJ. Placement of a permanent tunnelled peritoneal drainage catheter for palliation of malignant ascites: A simplified percutaneous approach. J Vasc Interv Radiol, 2002; 13:379–383.
